CytomX Therapeutics, Inc.

CTMX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$38,052$17,171$193,650$205,530
Short-Term Investments$62,571$157,338$0$99,696
Receivables$3,103$3,432$35,986$790
Inventory$0$0$0$0
Other Curr. Assets$3,579$4,995$7,466$4,285
Total Curr. Assets$107,305$182,936$237,102$310,301
Property Plant & Equip (Net)$10,603$16,178$21,021$25,322
Goodwill$949$949$949$949
Intangibles$583$729$875$1,021
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,093$1,000$944$1,818
Total NC Assets$13,228$18,856$23,789$29,110
Other Assets$0$0$0$0
Total Assets$120,533$201,792$260,891$339,411
Liabilities
Payables$1,088$1,458$2,809$2,818
Short-Term Debt$5,145$4,589$4,082$3,618
Tax Payable$0$0$0$0
Deferred Revenue$67,201$132,267$121,267$40,816
Other Curr. Liab.$12,338$17,599$24,450$30,618
Total Curr. Liab.$85,772$155,913$152,608$77,870
LT Debt$4,240$9,385$13,975$18,056
Deferred Rev, NC$26,862$80,048$180,059$243,944
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$4,115$3,893$0$0
Total NC Liab.$35,217$93,326$194,034$262,000
Other Liabilities$0$0$0$0
Cap. Leases$9,385$13,974$18,057$21,674
Total Liabilities$120,989$249,239$346,642$339,870
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$1$1
Retained Earnings-$691,579-$723,448-$722,879-$623,562
AOCI$27$95$10-$242
Other Equity$691,095$675,905$637,117$623,344
Total Equity-$456-$47,447-$85,751-$459
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$120,533$201,792$260,891$339,411
Net Debt-$28,667-$3,197-$175,593-$183,856